What Happened
A pharmacist at a pharmacy in Wicomico County, Maryland, admitted creating a fictitious patient profile and using it to fill and purchase prescriptions for herself, including phentermine, cyclobenzaprine, tizanidine, and gabapentin.
The Board found that the pharmacist diverted prescription drugs and/or controlled dangerous substances, with four phentermine prescriptions identified as suspicious and purchased using cash and two patient profiles. The pharmacist's license was suspended for at least one year effective April 8, 2025, with a $1,000 fine and a substance use evaluation; in a related criminal case, the pharmacist entered an agreement statement of facts to one count of obtaining a prescription drug by fraud and received probation before judgment and one year of unsupervised probation.
What the Record Shows
Consent Order: summary suspension lifted; license suspended effective April 8, 2025, for at least one year; $1,000 fine; substance use evaluation; possible rehabilitation contract; may petition to modify after six months and lift after one year; criminal case: agreement statement of facts to one count of obtaining a prescription drug by fraud, probation before judgment, one year unsupervised probation.
Why It Matters for Diversion Programs
This entry comes from a primary source rather than a federal enforcement release, and it is recorded as reported: Created a fictitious patient profile and used it to fill and purchase prescriptions for herself; recorded prescriptions as transmitted via telephone by a physician assistant; purchased with cash; used her driver's license to complete a purchase; diverted multiple prescription drugs and/or CDS.. Board and news records are a lagging indicator - by the time a licensing authority or a reporter learns of a diversion, the diversion was normally detected internally first, which makes each entry a signal that inventory reconciliation, waste observation or dispensing oversight failed earlier.